Skip to main content

Table 2 Multivariate competing risk model for LC-SM in patients with lung ASC

From: A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma

Characteristics

Coefficient

SHR (95% CI)

P

Age

0.008

 

0.15

Age’

0.003

 

0.62

Sex

 Female

Reference

Reference

 

 Male

0.228

1.26 (1.13–1.40)

< 0.001

Surgery

 No

   

 Yes

−0.798

0.45 (0.39–0.52)

< 0.001

T stage

 T1

Reference

Reference

 

 T2

0.416

1.52 (1.30–1.77)

< 0.001

 T3

0.817

2.26 (1.82–2.81)

< 0.001

 T4

0.783

2.19 (1.82–2.63)

< 0.001

N stage

 N0

Reference

Reference

 

 N1

0.398

1.49 (1.26–1.76)

< 0.001

 N2

0.5

1.65 (1.43–1.90)

< 0.001

 N3

0.469

1.60 (1.28–2.00)

< 0.001

M stage

 M0

Reference

Reference

 

 M1

0.477

1.61 (1.40–1.86)

< 0.001

  1. Abbreviations: ASC adenosquamous carcinoma, CI confidence interval, LC-SM lung cancer-specific mortality, SHR subdistribution hazard ratio